Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 16/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14077127 | 0.83 | ADRB2 (0.56) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL27717348 | 0.81 | ADRB2 (0.59) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL8879323 | 0.81 | ADRB2 (0.61) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| Hydrochloric Acid SCHEMBL27738410 | 0.81 | ADRB2 (0.58) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL4739379 | 0.80 | ADRB2 (0.53) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL3685868 | 0.79 | ADRB2 (0.49) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL1683034 | 0.79 | ADRB2 (0.59) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL14291843 | 0.79 | ADRB2 (0.52) | ADRB2ADRB1 | |
| SCHEMBL7840281 | 0.79 | ADRB2 (0.47) | ADRB2ABCB11ADRB1DRD2PDE4A | |
| SCHEMBL4740762 | 0.79 | ADRB2 (0.52) | ADRB2ABCB11ADRB1DRD2PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121642-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008075026-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2008-06-26 | — | — | WO | disclosed |